Introduction {#sec0005}
============

COVID-19 pneumonia is caused by SARS-CoV-2 that has caused a widespread epidemic, posing a serious threat to global health. Patients diagnosed with COVID-19 at admission are usually confirmed to have pneumonia \[[@bib0005]\]. As the designated hospital for the treatment of such patients, our center found that COVID-19 patients with normal chest CT imaging findings were unusual in clinical practice \[[@bib0010]\]. Asymptomatic patients and infected patients with normal chest images are considered carriers of SARS-CoV-2, requiring timely clinical intervention and management \[[@bib0015]\]. Here, we first discuss a patient who was diagnosed with COVID-19 but had no pulmonary lesions on chest CT at the time of admission and was confirmed to have COVID-19 pneumonia during her hospital stay. The clinical problems encountered in treating such patients are discussed.

Case presentation {#sec0010}
=================

A 26-year-old woman developed a fever (37.9 °C \[100.22 °F\]) on January 27, 2020 ([Fig. 1](#fig0005){ref-type="fig"} ) after her brother returned to Shanghai, China, from a business trip to Wuhan, China (from January 13, 2020 to January 17, 2020), where COVID-19 was spreading \[[@bib0020]\]. She subsequently went to the hospital and was tested with a real-time polymerase chain reaction (RT-PCR) assay of a throat swab sample to detect SARS-CoV-2. She was then diagnosed with COVID-19. Later, her brother was also diagnosed with COVID-19. At admission, she had no cough, sputum or shortness of breath (January 29, 2020). Fever was the only clinical manifestation, and chest CT showed that the bilateral lungs were clear ([Fig. 2](#fig0010){ref-type="fig"} A and B). Laboratory studies showed that all items of the routine blood tests were normal at admission. Several additional laboratory tests were abnormal, including low-density lipoprotein (2.02 mmol/L; normal range 2.6--4.1 mmol/L) and erythrocyte sedimentation rate (32 mm/h; normal range 0.0--20.0 mm/h) \[[@bib0025]\]. She was treated with symptomatic treatment and lopinavir-ritonavir during the hospital stay. In the early days of the epidemic, there was a lack of systematic understanding of COVID-19. Because the patient's clinical symptoms did not subside, CT imaging was used to assess the evolution of the disease. On the 5th day after admission (February 3, 2020), a few ground-glass opacities were found in the subpleural area of the right lower lobe on chest CT ([Fig. 2](#fig0010){ref-type="fig"}C and D). Then, her clinical symptoms improved, and chest CT images (February 9, 2020) showed a reduction in the size of the ground-glass opacities ([Fig. 2](#fig0010){ref-type="fig"}E and F). The chest CT imaging results, clinical manifestations, and laboratory tests were not completely consistent during the clinical course \[[@bib0030]\].Fig. 1Timeline of the entire incidence from exposure to the index patient to the current patient showing symptoms, the evolution of test results and the clinical course.Fig. 1Fig. 2Images of a 26-year-old woman diagnosed with COVID-19. (A and B) CT scans obtained at admission show that the bilateral lungs are clear. (C and D) CT scans obtained on day 5 show ground-glass opacities in the subpleural area of the right lower lobe. (E and F) CT scans obtained on day 11 show partial resolution.Fig. 2

Discussion {#sec0015}
==========

At present, the source of infection for COVID-19 is mainly infected patients, and asymptomatic patients are highly likely to carry and spread the virus \[[@bib0010],[@bib0015]\]. The main routes of human-to-human transmission of COVID-19 are via droplets expelled from the respiratory tract and direct or indirect contact, and the entire population is generally susceptible \[[@bib0035]\]. Thus, clinical management needs to be carried out as soon as possible for those who have reliable epidemiological information and clinical symptoms.

By describing a patient with confirmed COVID-19 without pulmonary lesions on chest CT at admission, our case provides the initial clinical manifestations, laboratory assay results and chest CT images of a patient with COVID-19, which is different from the studies that have been reported so far \[[@bib0005],[@bib0010]\]. As one of the main respiratory infections, pneumonia caused by a SARS-CoV-2 infection is of great help to make an early clinical diagnosis. However, for patients with a suspected COVID-19 infection with specific clinical information, a one-time CT examination cannot rule out the possibility of COVID-19. Further diagnostic tests should include RT-PCR assays, and follow-up CT imaging of the chest is also recommended.

Conclusions {#sec0020}
===========

For patients with suspected COVID-19 infections with reliable epidemiological information and clinical symptoms, the chest CT findings can be negative, and RT-PCR assays are needed to make a further diagnosis.
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